AstraZeneca (Hong Kong)

In the global effort to meet the growing demand for healthcare, our innovation has a vital role to play.


About Us

Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialization of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation.

Read more


Value of medicine

The path to a new medicine is a long and complex process, requiring a major commitment of time, money and resource. Here, you can take a walk along this path to see the steps we take to bring to market new medicines that make a real contribution to healthcare.

Read more


Our R&D facilities

AstraZeneca R&D employs over 11,000 people at research facilities in the UK, the US, Sweden, France, Canada, India, China and Japan, complemented by a worldwide clinical development capability.

Read more


This website is intended for people seeking information on AstraZeneca's Hong Kong business.
We also have national business sites; links to these are under 'AstraZeneca Worldwide'.